Printed From:

KEVZARA Offers Consistent Every-2-Week Dosing for Your Patients1

Recommended dose is 200 mg every 2 weeks as a subcutaneous injection1

  • Recommended dose is 200 mg every 2 weeks as a subcutaneous injection1

  • KEVZARA can be used with or without MTX or other conventional DMARDs1*

  • Reduce the 200 mg dose to 150 mg for the management of neutropenia, thrombocytopenia, or elevated liver enzymes1

    • Click here for dosing considerations for patient management

*Dosing of MTX and other conventional DMARDs may vary.

KEVZARA is available by prescription only.

KEVZARA comes in a prefilled syringe that must be refrigerated, but can be kept at room temperature for up to 14 days, if needed1

Ease of Use

Both the KEVZARA packaging and prefilled syringe received the Arthritis Foundation Ease of Use Commendation after independent testing by experts and evaluation by people with arthritis. Products receiving the Commendation make certain aspects of life easier for people with RA.2,3

DMARD=disease-modifying antirheumatic drug.

References: 1. KEVZARA [prescribing information]. Bridgewater, NJ: Sanofi/Regeneron Pharmaceuticals, Inc; 2017. 2. Ease of use products. Arthritis Foundation website. http://www.arthritis.org/living-with-arthritis/tools-resources/ease-of-use. Accessed October 10, 2017. 3. Data on file, Sanofi/Regeneron. Regeneron Sarilumab Evaluation Report of Consumer Product Accessibility for Users with Arthritis. February 2015.